Oncotelic Therapeutics, Inc. Deferred Tax Assets, Capital Loss Carryforwards
Oncotelic Therapeutics, Inc. (OTLC) had Deferred Tax Assets, Capital Loss Carryforwards of $528.00 thousand as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2026-04-15
- 2025-12-31: Deferred Tax Assets, Capital Loss Carryforwards $528.00K.
- 2024-12-31: Deferred Tax Assets, Capital Loss Carryforwards $528.00K.
- 2023-12-31: Deferred Tax Assets, Capital Loss Carryforwards $528.00K.
- 2022-12-31: Deferred Tax Assets, Capital Loss Carryforwards $528.00K.
| Period end | Deferred Tax Assets, Capital Loss Carryforwards | Deferred Tax Assets, Capital Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $528.00K 10-K · filed 2026-04-15 | |
| 2024-12-31 | $528.00K 10-K · filed 2026-04-15 | |
| 2023-12-31 | $528.00K 10-K · filed 2025-04-15 | |
| 2022-12-31 | $528.00K 10-K · filed 2024-04-12 | |
| 2021-12-31 | $528.00K 10-K/A · filed 2023-04-20 | |
| 2021-09-30 | $528.00K 10-Q · filed 2021-11-22 | |
| 2021-06-30 | $528.00K 10-Q · filed 2021-08-20 | |
| 2021-03-31 | $528.00K 10-Q · filed 2021-05-24 | |
| 2020-12-31 | $528.00K 10-K · filed 2022-04-15 | $528.00 10-K · filed 2021-04-15 |
| 2013-12-31 | $1.36M 10-K · filed 2015-03-30 | |
| 2012-12-31 | $1.59M 10-K · filed 2014-03-20 | |
| 2011-12-31 | $1.49M 10-K · filed 2013-03-15 | |
| 2009-12-31 | $1.36M 10-K · filed 2015-03-30 |